| Dupilumab treatment in adults with moderate-to-severe atopic dermatitis LA Beck, D Thaçi, JD Hamilton, NM Graham, T Bieber, R Rocklin, JE Ming, ... New England Journal of Medicine 371 (2), 130-139, 2014 | 1453 | 2014 |
| Dupilumab in persistent asthma with elevated eosinophil levels S Wenzel, L Ford, D Pearlman, S Spector, L Sher, F Skobieranda, L Wang, ... New England journal of medicine 368 (26), 2455-2466, 2013 | 1442 | 2013 |
| Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial C Bachert, L Mannent, RM Naclerio, J Mullol, BJ Ferguson, P Gevaert, ... Jama 315 (5), 469-479, 2016 | 809 | 2016 |
| Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis JD Hamilton, M Suárez-Farinas, N Dhingra, I Cardinale, X Li, A Kostic, ... Journal of Allergy and Clinical Immunology 134 (6), 1293-1300, 2014 | 477 | 2014 |
| Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment … M de Bruin‐Weller, D Thaçi, CH Smith, K Reich, MJ Cork, A Radin, ... British Journal of Dermatology 178 (5), 1083-1101, 2018 | 466 | 2018 |
| The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study R Terkeltaub, JS Sundy, HR Schumacher, F Murphy, S Bookbinder, ... Annals of the rheumatic diseases 68 (10), 1613-1617, 2009 | 369 | 2009 |
| Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis I Hirano, ES Dellon, JD Hamilton, MH Collins, K Peterson, M Chehade, ... Gastroenterology 158 (1), 111-122. e10, 2020 | 353 | 2020 |
| Leukotriene B4 is a complete secretagogue in human neutrophils: a kinetic analysis CN Serhan, A Radin, JE Smolen, H Korchak, B Samuelsson, ... Biochemical and biophysical research communications 107 (3), 1006-1012, 1982 | 309 | 1982 |
| Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from … TWJ Huizinga, RM Fleischmann, M Jasson, AR Radin, J van Adelsberg, ... Annals of the rheumatic diseases 73 (9), 1626-1634, 2014 | 282 | 2014 |
| Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis G Yosipovitch, M Reaney, V Mastey, L Eckert, A Abbé, L Nelson, M Clark, ... British Journal of Dermatology 181 (4), 761-769, 2019 | 249 | 2019 |
| Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement JM Orengo, AR Radin, V Kamat, A Badithe, LH Ben, BL Bennett, S Zhong, ... Nature communications 9 (1), 1421, 2018 | 200 | 2018 |
| Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN) J Sieper, J Braun, J Kay, S Badalamenti, AR Radin, L Jiao, S Fiore, ... Annals of the Rheumatic Diseases 74 (6), 1051-1057, 2015 | 167 | 2015 |
| Rilonacept (interleukin‐1 trap) in the prevention of acute gout flares during initiation of urate‐lowering therapy: results of a phase II randomized, double‐blind, placebo … HR Schumacher Jr, JS Sundy, R Terkeltaub, HR Knapp, SJ Mellis, ... Arthritis & Rheumatism 64 (3), 876-884, 2012 | 139 | 2012 |
| Long‐term safety and efficacy of rilonacept in patients with systemic juvenile idiopathic arthritis DJ Lovell, EH Giannini, AO Reiff, Y Kimura, S Li, PJ Hashkes, CA Wallace, ... Arthritis & Rheumatism 65 (9), 2486-2496, 2013 | 136 | 2013 |
| Independent effects of IgG and complement upon human polymorphonuclear leukocyte function IM Goldstein, HB Kaplan, A Radin, M Frosch The Journal of Immunology 117 (4), 1282-1287, 1976 | 132 | 1976 |
| Salmonella bacteremia in systemic lupus erythematosus. Eight‐year experience at a municipal hospital S Abramson, SB Kramer, A Radin, R Holzman Arthritis & Rheumatism: Official Journal of the American College of …, 1985 | 116 | 1985 |
| Use of an IL-1 antagonist for treating arthritis S Mellis, N Stahl, A Radin, S Weinstein, D Calaprice, M Karow, ... US Patent 7,361,350, 2008 | 115 | 2008 |
| Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases JD Hamilton, S Harel, BN Swanson, W Brian, Z Chen, MS Rice, N Amin, ... Clinical & Experimental Allergy 51 (7), 915-931, 2021 | 89 | 2021 |
| Stimulus response coupling in the human neutrophil. Differential requirements for receptor occupancy in neutrophil responses to a chemoattractant. HM Korchak, C Wilkenfeld, AM Rich, AR Radin, K Vienne, LE Rutherford Journal of Biological Chemistry 259 (12), 7439-7445, 1984 | 74 | 1984 |
| Dupilumab treatment improves quality of life in adult patients with moderate‐to‐severe atopic dermatitis: results from a randomized, placebo‐controlled clinical trial A Tsianakas, TA Luger, A Radin British Journal of Dermatology 178 (2), 406-414, 2018 | 70 | 2018 |
